Renato Bisonni
About
Renato Bisonni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology.
According to data from OpenAlex, Renato Bisonni has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Renato Bisonni's work include Colorectal Cancer Treatments and Studies (16 papers), Gastric Cancer Management and Outcomes (9 papers) and Genetic factors in colorectal cancer (5 papers). Renato Bisonni is often cited by papers focused on Colorectal Cancer Treatments and Studies (16 papers), Gastric Cancer Management and Outcomes (9 papers) and Genetic factors in colorectal cancer (5 papers). Renato Bisonni collaborates with scholars based in Italy, Japan and United States. Renato Bisonni's co-authors include Francesco Graziano, Lucio Giustini, Vincenzo Catalano, Paolo Giordani, Daniele Santini, Alfredo Falcone, Fotios Loupakis, Mauro Magnani, Annamaria Ruzzo and Giuseppe Tonini and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.
In The Last Decade
Renato Bisonni
31 papers receiving 1.3k citations
Peers
Renato Bisonni
Ken Shimada Japan
Michael Eschenberg United States
Petra Ruemmele Germany
Russell J. Nauta United States
Hayakazu Nakazawa Japan
Hsiang‐Lin Tsai Taiwan
Hideyuki Mishima Japan
Yuichiro Takeda Japan
James B. Gerstner United States
Jérôme Alexandre France
Citations per year, relative to Renato Bisonni Renato Bisonni (= 1×)
peers
Ken Shimada
Countries citing papers authored by Renato Bisonni
Since
Specialization
Citations
This map shows the geographic impact of Renato Bisonni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renato Bisonni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renato Bisonni more than expected).
Fields of papers citing papers by Renato Bisonni
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Renato Bisonni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renato Bisonni. The network helps show where Renato Bisonni may publish in the future.
Co-authorship network of co-authors of Renato Bisonni
This figure shows the co-authorship network connecting the top 25 collaborators of Renato Bisonni. A scholar is included among the top collaborators of Renato Bisonni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renato Bisonni. Renato Bisonni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Torniai, Mariangela, et al.. (2025). Case Report: Pembrolizumab in a patient with preexisting paraneoplastic dermatomyositis and sarcomatoid urothelial carcinoma. Searching for balance. Frontiers in Immunology. 16. 1558964–1558964.
2.
Giampieri, Riccardo, Alessandro Bittoni, Francesca Rastelli, et al.. (2023). Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy. Cancers. 15(13). 3342–3342.
3.
Bittoni, Alessandro, Riccardo Giampieri, Federica Pecci, et al.. (2021). Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients. Current Oncology. 28(5). 3525–3536.
4.
Catalano, Vincenzo, Francesca Bergamo, Chiara Cremolini, et al.. (2018). Optimizing the use of first-line chemotherapy in metastatic colorectal cancer patients with mucinous histology. A multicenter, retrospective, combined analysis on 897 patients. Annals of Oncology. 29. v97–v97.
5.
Catalano, Vincenzo, Renato Bisonni, Francesco Graziano, et al.. (2012). A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases. Gastric Cancer. 16(3). 411–419.
6.
Catalano, Vincenzo, Fotios Loupakis, Francesco Graziano, et al.. (2011). Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Annals of Oncology. 23(1). 135–141.
7.
Canestrari, Emanuele, Annamaria Ruzzo, Bruno Vincenzi, et al.. (2011). Let-7a microRNA levels in KRAS-mutated colorectal carcinomas determine survival differences in patients treated with anti-EGFR.. Journal of Clinical Oncology. 29(15_suppl). 3635–3635.
8.
Scartozzi, Mario, Alessandra Mandolesi, Riccardo Giampieri, et al.. (2010). Insulin‐like growth factor 1 expression correlates with clinical outcome in K‐RAS wild type colorectal cancer patients treated with cetuximab and irinotecan. International Journal of Cancer. 127(8). 1941–1947.
9.
Graziano, Francesco, Annamaria Ruzzo, Emanuele Canestrari, et al.. (2010). Host Genetic Variants in the IGF Binding Protein-3 Impact on Survival of Patients with Advanced Gastric Cancer Treated with Palliative Chemotherapy. Pharmacogenomics. 11(9). 1247–1256.
10.
Rastelli, Francesca, et al.. (2010). Continuity of care for cancer patients at the end of life (EoL).. Journal of Clinical Oncology. 28(15_suppl). 6145–6145.
11.
Catalano, Vincenzo, Fotios Loupakis, Francesco Graziano, et al.. (2009). Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. British Journal of Cancer. 100(6). 881–887.
12.
Ruzzo, Annamaria, Emanuele Canestrari, Fotios Loupakis, et al.. (2008). Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer. The Pharmacogenomics Journal. 9(1). 78–84.
13.
Graziano, Francesco, Annamaria Ruzzo, Fotios Loupakis, et al.. (2008). Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy. British Journal of Cancer. 99(5). 716–721.
14.
Ruzzo, Annamaria, Emanuele Canestrari, Paolo Enrico Maltese, et al.. (2007). Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 45(7). 822–8.
15.
Mancinelli, Angelo, S D'Iddio, Renato Bisonni, et al.. (2006). Urinary excretion of l-carnitine and its short-chain acetyl-l-carnitine in patients undergoing carboplatin treatment. Cancer Chemotherapy and Pharmacology. 60(1). 19–26.
16.
Massacesi, Cristian, Salvatore Terrazzino, F. Marcucci, et al.. (2006). Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan‐based chemotherapy. Cancer. 106(5). 1007–1016.
17.
Ruzzo, Annamaria, Francesco Graziano, Kazuyuki Kawakami, et al.. (2006). Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy. Journal of Clinical Oncology. 24(12). 1883–1891.
18.
Graziano, Francesco, Kazuyuki Kawakami, Annamaria Ruzzo, et al.. (2005). Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at‐risk Italian population. International Journal of Cancer. 118(3). 628–632.
19.
Mattioli, Rodolfo, P. Lippe, Cristian Massacesi, et al.. (2004). Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trial.. PubMed. 24(5B). 3257–61.
20.
Graziano, Francesco, Renato Bisonni, Vincenzo Catalano, et al.. (2002). Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients. British Journal of Cancer. 86(12). 1854–1857.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ken Shimada Breakdown of academic impact, for papers by Michael Eschenberg Breakdown of academic impact, for papers by Petra Ruemmele Breakdown of academic impact, for papers by Russell J. Nauta Breakdown of academic impact, for papers by Hayakazu Nakazawa Breakdown of academic impact, for papers by Hsiang‐Lin Tsai Breakdown of academic impact, for papers by Hideyuki Mishima Breakdown of academic impact, for papers by Yuichiro Takeda Breakdown of academic impact, for papers by James B. Gerstner Breakdown of academic impact, for papers by Jérôme Alexandre